{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T09:31:52Z","timestamp":1793179912437,"version":"4.5.0"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T00:00:00Z","timestamp":1734566400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec><jats:title>Background and purpose<\/jats:title><jats:p>The aim was to estimate the cost of the external beam radiotherapy (EBRT) in public health care centers in Catalonia (Spain), according to the ESTRO-HERO costing model for 2018.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and methods<\/jats:title><jats:p>Personnel, equipment, and activity data from 2018 from the 11 RT centers were used, incorporating European mean values adapted to the Catalan context. Secondly, EBRT costs were estimated, incorporating 2023 fractionation technique and scheme usage percentages. Finally, complementary estimates were included: complementary planning examinations, stereotactic body radiation therapy (SBRT) fiducial markers, and hospital overhead costs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In 2018, EBRT cost was estimated at EUR 42.2 M for all patients in the region. Directly related treatment activities represented 69.0% of the total cost, while support and non-directly related EBRT activities accounted for 20.2 and 10.8%, respectively. Mean radical treatment cost varied from \u20ac1714 (leukemia) to \u20ac4,645 (pancreas), and for palliative intent, from \u20ac938 (bone metastases) to \u20ac1753 (brain metastases). According to the technique used, costs ranged from \u20ac1,475 (3D conformal) to \u20ac3,608 (rotational IMRT), and by fractionation scheme, from \u20ac1,308 (extreme hypofractionation) to \u20ac4,094 (standard fractionation). Accounting for 2023 complexity levels, mean treatment cost rose by 0.9%, but varied widely by tumor site, with a 13% increase for stomach cancer, and decreases of \u221215.0, \u221224.4, and\u202f\u2212\u202f17.2% in myeloma, pancreas, and lung cancer, respectively. Including complementary examinations and hospital overhead costs, mean cost increased by 15.6%.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study provides a first approximation to EBRT cost using time-driven activity-based costing (TD-ABC) in Catalonia showing the feasibility of the assessment. For each indication, average treatment cost increases with the associated complexity. Additionally, costs decrease with hypofractionation schemes, largely due to lower equipment weight in treatment cost. Consequently, the adoption of stereotactic techniques is driving cost decreases. Overall, this model represents a robust tool for analyzing different possible scenarios, including changes in fractionation and complexity.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpubh.2024.1474376","type":"journal-article","created":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T12:56:42Z","timestamp":1734613002000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Challenges in assessing national radiotherapy costs: application of the ESTRO-HERO model in Spain"],"prefix":"10.3389","volume":"12","author":[{"given":"Julieta","family":"Corral","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manel","family":"Algara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carles","family":"Mu\u00f1oz-Montplet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arantxa","family":"Eraso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Giralt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"No\u00e9mie","family":"Defourny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolande","family":"Lievens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep Maria","family":"Borras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,12,19]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.radonc.2011.12.026","article-title":"Health economics in radiation oncology: introducing the ESTRO HERO project","volume":"103","author":"Lievens","year":"2012","journal-title":"Radiother Oncol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.radonc.2011.07.033","article-title":"The cost of radiotherapy in a decade of technology evolution","volume":"102","author":"van de Werf","year":"2012","journal-title":"Radiother Oncol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.clon.2014.10.010","article-title":"HERO (health economics in radiation oncology): a Pan-European project on radiotherapy resources and needs","volume":"27","author":"Lievens","year":"2015","journal-title":"Clin Oncol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.3109\/0284186X.2015.1066932","article-title":"Cost calculation, a necessary step towards widespread adoption of advanced radiotherapy technology","volume":"54","author":"Lievens","year":"2015","journal-title":"Acta Oncol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.radonc.2016.12.002","article-title":"Cost evaluations of radiotherapy: what do we know? An ESTRO-HERO analysis","volume":"121","author":"Defourny","year":"2016","journal-title":"Clin Transl Rad Oncol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.radonc.2019.06.015","article-title":"National costs and resource requirements of external beam radiotherapy: a time-driven activity-based costing model from the ESTRO-HERO project","volume":"138","author":"Defourny","year":"2019","journal-title":"Radiother Oncol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"7272","DOI":"10.1118\/1.4764914","article-title":"Consensus recommendations for incident learning database structures in radiation oncology","volume":"39","author":"Ford","year":"2012","journal-title":"Med Phys"},{"key":"ref8","volume-title":"Innovative radiotherapy techniques: a multicentre time-driven activity-based costing study","author":"Hulstaert","year":"2013"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1097\/JTO.0000000000000421","article-title":"Stereotactic body radiotherapy for lung cancer: how much does it really cost?","volume":"10","author":"Lievens","year":"2015","journal-title":"JTO"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1007\/s12094-017-1727-x","article-title":"Infrastructure and equipment for radiation oncology in the Spanish National Health System: analysis of external beam radiotherapy 2015-2020","volume":"20","author":"Rodr\u00edguez","year":"2018","journal-title":"Clin Transl Oncol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.canrad.2009.03.001","article-title":"The cost of respiration-gated radiotherapy in the framework of a clinical research programme \u201cSTIC\u201d","volume":"13","author":"Remonnay","year":"2009","journal-title":"Cancer Radiother"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00066-011-0003-1","article-title":"Time management in radiation oncology: development and evaluation of a modular system based on the example of rectal cancer treatment","volume":"188","author":"Fietkau","year":"2012","journal-title":"Strahlenther Onkol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s00066-014-0634-0","article-title":"Protection of quality and innovation in radiation oncology: the prospective multicenter trial the German Society of Radiation Oncology (DEGRO-QUIRO study)","volume":"190","author":"Vorwerk","year":"2014","journal-title":"Strahlenther Onkol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.radonc.2021.11.035","article-title":"Variable and fixed costs in NHS radiotherapy; consequences for increasing hypo fractionation","volume":"166","author":"Spencer","year":"2022","journal-title":"Radiother Oncol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.radonc.2020.01.024","article-title":"The financial impact of SBRT for oligometastatic disease: a population-level analysis in Belgium","volume":"145","author":"Nevens","year":"2020","journal-title":"Radiother Oncol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.radonc.2017.08.021","article-title":"Cost evaluation to optimise radiation therapy implementation in different income settings: A time-driven activity-based analysis","volume":"125","author":"Van Dyk","year":"2017","journal-title":"Radiother Oncol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.radonc.2017.11.005","article-title":"Adjuvant breast radiotherapy: how to trade-off cost and effectiveness?","volume":"126","author":"Monten","year":"2018","journal-title":"Radiother Oncol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"107013","DOI":"10.1016\/j.jaccpubpol.2022.107013","article-title":"Developing time-driven activity-based costing at the national level to support policy recommendations for radiation oncology in Belgium","volume":"42","author":"Defourny","year":"2023","journal-title":"J Account Public Policy"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s12913-015-0845-9","article-title":"Direct costs of radiotherapy for rectal cancer: a microcosting study","volume":"15","author":"Hanly","year":"2015","journal-title":"BMC Health Serv Res"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.ijrobp.2016.02.013","article-title":"Cost analysis of complex radiation therapy for patients with head and neck Cancer","volume":"95","author":"Perrier","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/S1470-2045(15)00222-3","article-title":"Expanding global access to radiotherapy","volume":"16","author":"Atun","year":"2015","journal-title":"Lancet Oncol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nrc.2016.18","article-title":"Radiation oncology in the era of precision medicine","volume":"16","author":"Baumann","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s12094-022-02963-z","article-title":"Machine learning-based automated planning for hippocampal avoidance prophylactic cranial irradiation","volume":"25","author":"de Dios N","year":"2023","journal-title":"Clin Transl Oncol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"e230023","DOI":"10.57264\/cer-2023-0023","article-title":"Redesign of radiotherapy for prostate cancer: a proposal for universal healthcare systems","volume":"12","author":"da Silva","year":"2023","journal-title":"J Comp Effect Res"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.radonc.2021.08.002","article-title":"Innovation, value and reimbursement in radiation and complex surgical oncology: time to rethink","volume":"169","author":"Borras","year":"2022","journal-title":"Radiother Oncol"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2024.1474376\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T12:56:45Z","timestamp":1734613005000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2024.1474376\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,19]]},"references-count":25,"alternative-id":["10.3389\/fpubh.2024.1474376"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2024.1474376","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,19]]},"article-number":"1474376"}}